Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:1429-1437, doi:10.1016/S0735-1097(03)01062-3
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirashiki, A.
Right arrow Articles by Yokota, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirashiki, A.
Right arrow Articles by Yokota, M.

CLINICAL RESEARCH: GENE POLYMORPHISMS AND CAD

Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors

Akihiro Hirashiki, MD*, Yoshiji Yamada, MD, PhD{dagger},*, Yosuke Murase, MD*, Yoriyasu Suzuki, MD*, Hiroki Kataoka, MD*, Yasutsugu Morimoto, MD*, Toru Tajika, MD*, Toyoaki Murohara, MD, PhD{ddagger} and Mitsuhiro Yokota, MD, PhD, FACC§

* Division of Cardiology, Okazaki City Hospital, Okazaki, Japan
{dagger} Department of Gene Therapy, Gifu International Institute of Biotechnology, Kakamigahara, Japan
{ddagger} Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
§ Department of Clinical Pathophysiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Manuscript received April 6, 2003; revised manuscript received May 30, 2003, accepted June 16, 2003.

* Reprint requests and correspondence: Dr. Yoshiji Yamada, FAHA, Department of Gene Therapy, Gifu International Institute of Biotechnology, 1-1 Naka-Fudogaoka, Kakamigahara, Gifu 504-0838, Japan.
yoyamada{at}giib.or.jp

OBJECTIVES: The aim of the study was to identify genes that confer susceptibility to coronary artery disease (CAD) in low- or high-risk men or women separately and thereby to assess the genetic risk of CAD in such individuals.

BACKGROUND: The prevention of CAD would be facilitated by the identification of genes that confer susceptibility to this condition independently in low- or high-risk individuals, as defined by conventional risk factors.

METHODS: The study population comprised 1,661 unrelated Japanese individuals, including 1,011 patients with CAD and 650 control subjects. Among all study subjects, 601 individuals (high-risk subjects) had hypertension, diabetes mellitus, and hypercholesterolemia, and 1,060 individuals (low-risk subjects) had none of these risk factors for CAD. The genotypes for 37 polymorphisms of 31 candidate genes were determined by a fluorescence- or colorimetry-based allele-specific DNA primer-probe assay system.

RESULTS: Multivariate logistic regression analysis, with adjustment for age, body mass index, and the prevalence of smoking and hyperuricemia, revealed that the –219G->T polymorphism of the apolipoprotein E gene in low-risk men, the –1171/5A->6A polymorphism of the stromelysin-1 gene in low-risk women, the 1019C->T polymorphism of the connexin 37 gene in high-risk men, and the 3932T->C polymorphism of the apolipoprotein E gene in high-risk women were significantly associated with CAD. A stepwise forward selection procedure revealed that the effects of these polymorphisms on CAD were statistically independent of age or conventional risk factors.

CONCLUSIONS: Genotyping of these polymorphisms may prove informative for assessment of the genetic risk of CAD in low- or high-risk men or women.

Abbreviations and Acronyms
  BMI = body mass index
  BP = blood pressure
  CAD = coronary artery disease
  HbA1c = glycosylated hemoglobin
  LDL = low-density lipoprotein
  MI = myocardial infarction
  SNP = single nucleotide polymorphism




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Cozzolino, M. L. Biondi, A. Galassi, O. Turri, D. Brancaccio, and M. Gallieni
Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2207 - 2212.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. Burnier, P. Fontana, A. Angelillo-Scherrer, and B. R. Kwak
Intercellular Communication in Atherosclerosis
Physiology, February 1, 2009; 24(1): 36 - 44.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
G. Kolovou, D. Damaskos, K. Anagnostopoulou, and D. V. Cokkinos
Apolipoprotein E Gene Polymorphism and Gender
Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 120 - 133.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
W. Koch, P. Hoppmann, A. de Waha, A. Schomig, and A. Kastrati
Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence
Hum. Mol. Genet., April 15, 2008; 17(8): 1120 - 1126.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. A. Iakoubova, C. H. Tong, C. M. Rowland, T. G. Kirchgessner, B. A. Young, A. R. Arellano, D. Shiffman, M. S. Sabatine, H. Campos, C. J. Packard, et al.
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
L. Ho, V. Bos, and A. E. Kunst
Differences in Cause-of-Death Patterns Between the Native Dutch and Persons of Indonesian Descent in the Netherlands
Am J Public Health, September 1, 2007; 97(9): 1616 - 1618.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S. Abilleira, S. Bevan, and H. S Markus
The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis
J. Med. Genet., December 1, 2006; 43(12): 897 - 901.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. F. Figueroa, B. E. Isakson, and B. R. Duling
Vascular Gap Junctions in Hypertension
Hypertension, November 1, 2006; 48(5): 804 - 811.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. P. Rossi, G. Maiolino, M. Zanchetta, D. Sticchi, L. Pedon, M. Cesari, D. Montemurro, R. De Toni, S. Zavattiero, and A. C. Pessina
The T-786C Endothelial Nitric Oxide Synthase Genotype Predicts Cardiovascular Mortality in High-Risk Patients
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1166 - 1174.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P G Horan, A R Allen, C C Patterson, M S Spence, P G McGlinchey, and P P McKeown
The connexin 37 gene polymorphism and coronary artery disease in Ireland.
Heart, March 1, 2006; 92(3): 395 - 396.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ye
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
Cardiovasc Res, February 15, 2006; 69(3): 636 - 645.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. C. Newby and J. L. Johnson
Genetic Strategies to Elucidate the Roles of Matrix Metalloproteinases in Atherosclerotic Plaque Growth and Stability
Circ. Res., November 11, 2005; 97(10): 958 - 960.
[Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
G. D. Kolovou, K. K. Anagnostopoulou, K. D. Salpea, D. B. Panagiotakos, I. S. Hoursalas, M. A. Cariolou, K. Koniavitou, and D. V. Cokkinos
Apolipoprotein E Genotype in Matched Men and Women with Coronary Heart Disease
Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 391 - 396.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
N. P. Kadoglou, S. S. Daskalopoulou, D. Perrea, and C. D. Liapis
Matrix Metalloproteinases and Diabetic Vascular Complications
Angiology, March 1, 2005; 56(2): 173 - 189.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
W. Koch, J. Mehilli, A. Pfeufer, A. Schomig, and A. Kastrati
Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting
J. Lipid Res., December 1, 2004; 45(12): 2221 - 2226.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. P. Rossi, G. Maiolino, J. P. Casas, A. D. Hingorani, S. E. Humphries, L. Smeeth, and L. E. Bautista
Do Meta-Analyses of Association Studies of Endothelial Nitric Oxide Synthase Variants and Ischemic Heart Disease Provide Conclusive Answers? * Response
Circulation, September 14, 2004; 110(11): e305 - e306.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. E. Lanfear, S. Marsh, S. Cresci, W. D. Shannon, J. A. Spertus, and H. L. McLeod
Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 165 - 167.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. P. Rossi and G. Maiolino
Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 209 - 209.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Hirashiki, Y. Yamada, and M. Yokota
Reply
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 209 - 210.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement